Related Experiment Video
Updated: Sep 19, 2025

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Macrophages Atp6v0d2 regulates XBP1-mediated cholesterol metabolism to suppress metabolic dysfunction-associated
Ziyi Wang1, Xuejiao Chen2, Jie Li1
1Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing, China; NHC Key Laboratory of Hepatobiliary Cancers, (Nanjing Medical University), Nanjing, China.
Background:
Myeloid-derived macrophages (MDMs) play a spatiotemporally regulated and pivotal role in the progression of metabolic dysfunction-associated steatohepatitis (MASH). Among these, Atp6v0d2, a macrophage-specific lysosomal gene associated with Trem2, has been identified as significantly upregulated in MASH livers through single-cell RNA sequencing analysis and clinical sample validation. However, the mechanism of Atp6v0d2 in MASH pathogenesis remains unclear. This study aims to elucidate the functional significance of Atp6v0d2 in MASH and explore its potential as a therapeutic target.
Methods:
To investigate role of myeloid-derived macrophage Atp6v0d2, we generated myeloid Atp6v0d2 knockout(Atp6v0d2fl/fl;Lyz2-cre, Atp6v0d2Δmye), Atp6v0d2 global knockout (Atp6v0d2-/-), R26-e(CAG-LSL-Trem2-2 A-tdToamto) mice, myeloid Trem2 knockout(Trem2fl/fl;Lyz2-cre, Trem2Δmye). These models were studied in two diet-induced obesity (DIO) male mouse models-GAN and CDAHFD.
Results:
Our study reveals that Atp6v0d2 is significantly upregulated in MDMs within MASH livers. Atp6v0d2 deficiency exacerbated hepatic steatosis, fibrosis in DIO mice, while its upregulation in MDMs conferred protection against MASH progression. Mechanistically, Atp6v0d2 deficiency triggered XBP1-regulated endoplasmic reticulum stress in macrophages, leading to the impaired transition of macrophages towards an anti-inflammatory phenotype while concurrently aggravating macrophage apoptosis and impaired cholesterol efflux. Cholesterol overload in Atp6v0d2-deficient macrophages further disrupted Trem2 + macrophages efferocytosis, resulting in the accumulation of apoptotic, lipid-laden hepatocytes. This process was linked to the blockade of downstream LXR/MerTK. Administration of TAK-242 (Resatorvid), which induces Atp6v0d2 overexpression, ameliorated MASH-related pathology.
Conclusion:
We uncovered a critical role of myeloid-specific Atp6v0d2 in maintaining hepatic lipid homeostasis and suppressing MASH progression. Targeted activation of Atp6v0d2 as a promising therapeutic strategy for MASH.
Insights
Activating Atp6v0d2 in myeloid cells protects against metabolic dysfunction-associated steatohepatitis (MASH). This gene
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Metabolic dysfunction-associated steatohepatitis (MASH) involves myeloid-derived macrophages (MDMs).
- Atp6v0d2, a macrophage-specific gene linked to Trem2, is upregulated in MASH livers.
- The precise role of Atp6v0d2 in MASH pathogenesis requires elucidation.
Purpose of the Study:
- To investigate the functional significance of Atp6v0d2 in MDMs during MASH.
- To explore Atp6v0d2 as a potential therapeutic target for MASH.
Main Methods:
- Generated myeloid-specific Atp6v0d2 knockout mice (Atp6v0d2Δmye) and global knockout mice (Atp6v0d2-/-).
- Utilized myeloid Trem2 knockout mice (Trem2Δmye) and Trem2 reporter mice.
- Studied these models in diet-induced obesity (DIO) mouse models (GAN and CDAHFD).
Main Results:
- Atp6v0d2 deficiency in MDMs exacerbated hepatic steatosis and fibrosis in DIO mice.
- Upregulation of Atp6v0d2 conferred protection against MASH progression.
- Atp6v0d2 deficiency induced endoplasmic reticulum stress, impaired anti-inflammatory macrophage phenotype, increased apoptosis, and reduced cholesterol efflux, disrupting efferocytosis and leading to hepatocyte accumulation.
- Administration of TAK-242, inducing Atp6v0d2 overexpression, ameliorated MASH pathology.
Conclusions:
- Myeloid-specific Atp6v0d2 plays a critical role in maintaining hepatic lipid homeostasis and suppressing MASH.
- Targeted activation of Atp6v0d2 represents a promising therapeutic strategy for MASH.
Related Concept Videos
Inflammation
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of Nuclear Protein Sorting
Lipid Catabolism

